Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy
收藏DataCite Commons2025-04-16 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008654/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to
Severely Active Psoriatic Arthritis Subjects with Inadequate Response to Disease Modifying
anti-Rheumatic Drug Therapy
提供机构：
Vivli
创建时间：
2022-12-14
